These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7396323)

  • 1. [Aluminum gels in chronic kidney failrue patients. A potential risk of encephalopathy and osteopathy].
    Rottembourg J; Jaudon MC; Legrain M; Galli A
    Ann Med Interne (Paris); 1980; 131(2):71-4. PubMed ID: 7396323
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
    Wills MR; Savory J
    Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathogenic importance of aluminum].
    Porsová I; Blahos J
    Vnitr Lek; 1987 Apr; 33(4):376-82. PubMed ID: 3590635
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone and aluminum].
    Wendling D; Guidet M
    Rev Rhum Mal Osteoartic; 1986 Dec; 53(12):705-13. PubMed ID: 3103201
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I; Belovezhdov N
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract]   [Full Text] [Related]  

  • 7. Aluminum in tissues.
    Van de Vyver FL; De Broe ME
    Clin Nephrol; 1985; 24 Suppl 1():S37-57. PubMed ID: 3915959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
    Milne FJ; Sharf B; Bell P; Meyers AM
    Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aluminum-related bone disease in chronic hemodialysis patients].
    Jara A; Rosenberg H; Bruhn C; Vaccarezza A; Vial S; Jalil R; Cisternas H
    Rev Med Chil; 1993 Jul; 121(7):769-76. PubMed ID: 8296081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long term CaCO3 treatment of chronic hemodialysis patients--an attempt to prevent and treat aluminum osteopathy].
    Matsubara M; Totsune K; Saito T; Yoshinaga K; Unagami H; Sato H
    Nihon Jinzo Gakkai Shi; 1988 Nov; 30(11):1349-54. PubMed ID: 3236516
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum toxicity in patients with chronic renal failure.
    Alfrey AC
    Ther Drug Monit; 1993 Dec; 15(6):593-7. PubMed ID: 8122300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of orally administered aluminium hydroxide and results of withdrawal.
    Bournerias F; Monnier N; Reveillaud RJ
    Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis encephalopathy secondary to aluminum toxicity, diagnosed by bone biopsy.
    Andrade LG; Garcia FD; Silva VS; Gabriel DP; Rodrigues AG; Nascimento GV; Caramori JT; Martin LC; Barretti P; Balbi AL
    Nephrol Dial Transplant; 2005 Nov; 20(11):2581-2. PubMed ID: 16105866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aluminum osteopathy in a patient hemodialysed for chronic renal insufficiency and treated by long term administration of sucralfate].
    Level C; de Precigout V; Larroumet N; Blanchetier V; Potaux L; Aparicio M
    Rev Med Interne; 1996; 17(4):348-9. PubMed ID: 8761804
    [No Abstract]   [Full Text] [Related]  

  • 16. Dialysis encephalopathy associated with polyvalent ion contamination.
    Hocken AG
    N Z Med J; 1984 Mar; 97(752):190-2. PubMed ID: 6583579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Aluminum intoxication.
    N Engl J Med; 1976 May; 294(20):1129-31. PubMed ID: 1256537
    [No Abstract]   [Full Text] [Related]  

  • 18. Does gastric acid secretion affect phosphate binding by aluminium phosphate binding gels in chronic renal failure?
    Cassidy M; Swanepoel C; Bridger S; Marks IN
    Nephrol Dial Transplant; 1988; 3(3):358. PubMed ID: 3140119
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible aluminum intoxication.
    Nutr Rev; 1976 Jun; 34(6):166-7. PubMed ID: 781553
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.